After a $3.8 billion IPO, the J&J consumer-health business is leaning into communicating about its purpose and linking its new brand to its well-known products.
Patients value access to care, but feel let down: survey
The consumer health vet shares plans for the company’s Haleon spinoff, as well as thoughts on the ongoing shift toward consumer self-care and preventive health.
Pfizer to divest stake in GSK consumer health business